Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator

Takashi Yamaguchi(Jichi Medical University), Toshiya Inaba(Hiroshima University), Kosei Takeuchi(Aichi Medical University), Takashi Okada(The University of Tokyo), Tetsuji Tonda(Hiroshima University), M Ohtaki(Hiroshima University), K Ozawa(National Center For Child Health and Development), Soji Shinoda(Jichi Medical University), Toshio Masuzawa(Jichi Medical University)

Gene Therapy

February 25, 2003

10.1038/sj.gt.3301897

Cited by 22

Related Papers

Fusion of the Leucine Zipper Gene <i>HLF</i> to the <i>E2A</i> Gene in Human Acute B-Lineage Leukemia

|Science|1992|298

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia

|Blood|2003|277

Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay

|Blood|1989|276

Genomic organization, chromosomal localization, and independent expression of human cyclin D genes

|Genomics|1992|262

SLUG, a ces-1-Related Zinc Finger Transcription Factor Gene with Antiapoptotic Activity, Is a Downstream Target of the E2A-HLF Oncoprotein

|Molecular Cell|1999|208